BioMarin Shares Jump 5% After Global Patent Settlement With Ascendis
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s stock rose 5% on August 31 after the company announced that it has entered into binding agreements with Ascendis...
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Belfast Agreement"